Search

Your search keyword '"Jørgensen, Lone"' showing total 11 results
Start Over Author "Jørgensen, Lone" Language danish
11 results on '"Jørgensen, Lone"'

4. Trombocythaemning efter akutte og kroniske iskaemiske tilfaelde i hjerte og hjerne er utilstraekkelig i relation til rekommandationerne

Author

Aneta Aleksandra Nielsen, Karsten Tange Veien, Jørgensen, Lone G. M., Thomas Croft Buck, Ivan Brandslund, and Cramer Christensen

Subjects
Adult, Aged, 80 and over, Brain Infarction, Male, Ticlopidine, Aspirin, Myocardial Infarction, Dipyridamole, Middle Aged, Angina Pectoris, Brain Ischemia, Ischemic Attack, Transient, Diabetes Mellitus, Humans, Drug Therapy, Combination, Female, Angina, Unstable, Guideline Adherence, Acute Coronary Syndrome, Platelet Aggregation Inhibitors, Aged
Abstract

INTRODUCTION: Antiplatelet therapy is important in secondary prophylaxis in patients with ischemic heart, brain and vascular diseases. The aim of this study was to investigate the number of patients in Vejle County admitted to hospital in the second half of 2003 with acute and chronic heart, brain and vascular diseases to evaluate the kind of secondary prophylaxis and its duration. Moreover, the study registered the number of patients with diabetes mellitus treated with antiplatelet therapy. MATERIALS AND METHODS: The study included 2345 patients with ischemic heart, brain and vascular diseases, and patients with diabetes mellitus. Patients' data and information about medication were obtained from the hospital electronic database and public health insurance of Vejle County. Antiplatelet therapy was registered up to one year after onset of the disease. RESULTS: 1121 patients were admitted with cardiac diseases (including patients with angina pectoris), 624 patients had cerebral diseases, and 600 had diabetes mellitus. Acetylsalicylic acid (ASA) and a combination of ASA and clopidogrel were the most frequent forms of antiplatelet medication. Patients with diabetes and ischemic brain diseases made up 75% of those for whom medication was not registered. CONCLUSION: The study shows that in nearly all disease groups no antiplatelet therapy was registered for a very large number of % patients (up to 75%). A considerable number % of patients (up to 56%) with ischemic heart disease did not receive sufficient antiplatelet treatment according to Danish recommendations.

Published
2008

5. The Danish clinical guidelines (Klaringsrapporter, 1996-2001:Insufficient evidence presented for the diagnostic accuracy of recommended clinical-biochemical tests

Author

Jørgensen, Per E, Madsen, Jonna Skov, Jørgensen, Lone G, Larsen, Torben Bjerregaard, Hilden, Jørgen, and Magid, Erik

Subjects
Publishing, Evidence-Based Medicine, Reference Values, Denmark, Practice Guidelines as Topic, Journal Article, Humans, Reproducibility of Results, Guidelines as Topic, Biochemistry, Sensitivity and Specificity, Diagnostic Techniques and Procedures
Published
2004

8. [Arteriovenous malformation as a cause of intracerebral haemorrhage in a 13 year-old girl].

Author

Jørgensen LC and Longin E

Subjects
Adolescent, Cerebral Hemorrhage diagnosis, Cerebral Hemorrhage surgery, Diagnosis, Differential, Female, Headache diagnosis, Humans, Hydrocephalus diagnostic imaging, Intracranial Arteriovenous Malformations diagnosis, Intracranial Arteriovenous Malformations surgery, Tomography, X-Ray Computed, Cerebral Hemorrhage etiology, Intracranial Arteriovenous Malformations complications
Abstract

Spontaneous intracranial haemorrhages in children are rare. The leading cause of spontaneous bleeding is a rupture of arteriovenous malformations (AVM). This case study presents a 13 year-old girl with headache and slightly altered mental status due to bleeding from an unknown cerebral AVM. Although the initial symptoms may be non-specific it is a disease, which results in a significant mortality. A physician should keep the diagnosis in mind even though the incidence in children is very low.

Published
2012

9. [Antiplatelet treatment after acute and chronic ischemic heart and brain events is insufficient according to recommendations].

Author

Nielsen AA, Veien KT, Jørgensen LG, Buck TC, Brandslund I, and Christensen C

Subjects
Acute Coronary Syndrome prevention & control, Adult, Aged, Aged, 80 and over, Angina Pectoris prevention & control, Angina, Unstable prevention & control, Brain Infarction prevention & control, Clopidogrel, Dipyridamole therapeutic use, Drug Therapy, Combination, Female, Guideline Adherence, Humans, Ischemic Attack, Transient prevention & control, Male, Middle Aged, Ticlopidine therapeutic use, Aspirin therapeutic use, Brain Ischemia prevention & control, Diabetes Mellitus drug therapy, Myocardial Infarction prevention & control, Platelet Aggregation Inhibitors therapeutic use, Ticlopidine analogs & derivatives
Abstract

Introduction: Antiplatelet therapy is important in secondary prophylaxis in patients with ischemic heart, brain and vascular diseases. The aim of this study was to investigate the number of patients in Vejle County admitted to hospital in the second half of 2003 with acute and chronic heart, brain and vascular diseases to evaluate the kind of secondary prophylaxis and its duration. Moreover, the study registered the number of patients with diabetes mellitus treated with antiplatelet therapy., Materials and Methods: The study included 2345 patients with ischemic heart, brain and vascular diseases, and patients with diabetes mellitus. Patients' data and information about medication were obtained from the hospital electronic database and public health insurance of Vejle County. Antiplatelet therapy was registered up to one year after onset of the disease., Results: 1121 patients were admitted with cardiac diseases (including patients with angina pectoris), 624 patients had cerebral diseases, and 600 had diabetes mellitus. Acetylsalicylic acid (ASA) and a combination of ASA and clopidogrel were the most frequent forms of antiplatelet medication. Patients with diabetes and ischemic brain diseases made up 75% of those for whom medication was not registered., Conclusion: The study shows that in nearly all disease groups no antiplatelet therapy was registered for a very large number of % patients (up to 75%). A considerable number % of patients (up to 56%) with ischemic heart disease did not receive sufficient antiplatelet treatment according to Danish recommendations.

Published
2008

10. [The Danish clinical guidelines (Klaringsrapporter, 1996-2001: Insufficient evidence presented for the diagnostic accuracy of recommended clinical-biochemical tests].

Author

Jørgensen PE, Madsen JS, Jørgensen LG, Larsen TB, Hilden J, and Magid E

Subjects
Biochemistry standards, Denmark, Evidence-Based Medicine, Guidelines as Topic, Humans, Practice Guidelines as Topic, Publishing, Reference Values, Reproducibility of Results, Sensitivity and Specificity, Diagnostic Techniques and Procedures standards
Published
2004

11. [Diagnostics: new methodological initiatives].

Author

Magid E, Jørgensen PE, Jørgensen LG, Madsen JS, Larsen TB, and Hilden J

Subjects
Evidence-Based Medicine, Guidelines as Topic, Humans, Reproducibility of Results, Sensitivity and Specificity, Diagnosis, Diagnostic Techniques and Procedures standards
Published
2004

Catalog

Books, media, physical & digital resources
See catalog results